Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Nextleaf Solutions Ltd.

A pioneering force in the cannabis industry, driving innovation in extraction and life science technology.

 

Bullboard - Investor Discussion Forum Nextleaf Solutions Ltd C.OILS

Alternate Symbol(s):  OILFF

Nextleaf Solutions Ltd. is a cannabis processor with a portfolio of federally regulated emerging consumer brands, market validated cannabis derivative products, and high-potency bulk ingredients. The Company’s multi-patented, highly automated, closed loop extraction, and distillation technology sets the global standard for processing cannabis at scale. The Company manufactures over 80 different... see more

CSE:OILS - Post Discussion

Nextleaf Solutions Ltd > Just going to leave this here
View:
Post by GreenWave85 on Jan 28, 2021 11:37pm

Just going to leave this here

"As the Company has recently commenced generating revenues, its ability to continue operations will be largely reliant on its continued attractiveness to equity investors.

The Company is expected to incur operating losses as it continues to expend funds to develop its business operations. Even if its financial resources are sufficient to fund its current operations, there is no guarantee that the Company will be able to achieve its business objectives.


The continued development of Nextleaf is expected to require additional financing to fund further growth. The failure to raise such capital could result in the delay or indefinite postponement of current business objectives or the going out of business. The primary source of funding available to the Company will consist of equity financing.


There can be no assurance that additional capital or other types of financing will be available if needed or that, if available, the terms of such financing will be favourable. In addition, from time to time, the Company may enter into transactions to acquire assets or the shares of other corporations. These transactions may be financed wholly or partially with debt, which may temporarily increase the Company’s debt levels above industry standards"
Comment by LastoftheFranks on Jan 28, 2021 11:46pm
MD&A: $455,217 in licensing (royalty) fees from the Royalty Agreement executed in December 2019 with a private British Columbia company. Due to supply chain challenges and general market uncertainty as a result of COVID-19, Management’s has not determined annual guidance of expected revenue to be generated from the contract in fiscal 2021. Financials: As at September 30, 2020, the ...more  
Comment by LastoftheFranks on Jan 28, 2021 11:50pm
***Ignore the "Due to supply chain challenges and general market uncertainty as a result of COVID-19, Management’s has not determined annual guidance of expected revenue to be generated from the contract in fiscal 2021." attached to the end of financials section. Typo***
Comment by LastoftheFranks on Jan 28, 2021 11:58pm
These were always going to be sh*t seeing as most of the year was capex. Would've been nice to know about the licensing scandal with the manufacturer though.
Comment by ilvmyt5s on Jan 29, 2021 12:18am
They are doing alright considering loss of sales for Q3 due to COVID. Also some bad luck with a vendor and took a loss. They did get contracts and they only started commercialization 2H 2020. They need to cool it with the patents and spend more on sales. It's a good sign if consultants accept shares as payment. Wait and see what the raise is going to be like. Issued and outstanding is about ...more  
Comment by GreenWave85 on Jan 29, 2021 12:25am
I still see nothing to address costs and compensation levels.   Not all costs are fixed costs.  When you're losing money left, right and center it might be a good idea to reevaluate a) what you're spending money on AND b) how much money you're spending on discresionary spending and if the wages are in line with the value and capitalization being brought to the ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with C.OILS


Investor Presentation

View the Presentation

Investment Opportunity

  • Market Leadership with patented extraction and distillation technology offering significant efficiencies and higher purity levels over competing technologies
     
  • Debt free and four consecutive years of positive gross revenue. Reported fiscal YE 2023 gross revenue of $9.96MM with a gross profit of $2.3MM
     
  • Untapped domestic growth across various market segments, and the ability to scale production without additional capital expenditure
     
  • Backed by 19 U.S. patents and over 75 global patents provides a solid foundation for future growth and potential licensing opportunities

Nextleaf Solutions Ltd. With CEO, Emma Andrews

Primary Extraction

Distillation

Manufacturing: Softgels

The Vault

Facebook